A Pooled Analysis Evaluating the Efficacy and Tolerability of Tapentadol Extended Release for Chronic, Painful Diabetic Peripheral Neuropathy

por Schwartz, Sherwyn, Etropolski, Mila S., Shapiro, Douglas Y., Rauschkolb, Christine, Vinik, Aaron I., Lange, Bernd, Cooper, Kimberly, Van Hove, Ilse, Haeussler, Juergen
Publicado 2014

The selective orexin-2 antagonist seltorexant (JNJ-42847922/MIN-202) shows antidepressant and sleep-promoting effects in patients with major depressive disorder

por Recourt, Kasper, de Boer, Peter, Zuiker, Rob, Luthringer, Remy, Kent, Justine, van der Ark, Peter, Van Hove, Ilse, van Gerven, Joop, Jacobs, Gabriel, van Nueten, Luc, Drevets, Wayne
Publicado 2019

Correction to: The selective orexin-2 antagonist seltorexant (JNJ-42847922/MIN-202) shows antidepressant and sleep-promoting effects in patients with major depressive disorder

por Recourt, Kasper, de Boer, Peter, Zuiker, Rob, Luthringer, Remy, Kent, Justine, van der Ark, Peter, Van Hove, Ilse, van Gerven, Joop, Jacobs, Gabriel, van Nueten, Luc, Drevets, Wayne
Publicado 2019

The effects of inhibition of fatty acid amide hydrolase (FAAH) by JNJ-42165279 in social anxiety disorder: a double-blind, randomized, placebo-controlled proof-of-concept study

por Schmidt, Mark E., Liebowitz, Michael R., Stein, Murray B., Grunfeld, Jennifer, Van Hove, Ilse, Simmons, W. Kyle, Van Der Ark, Peter, Palmer, James A., Saad, Ziad S., Pemberton, Darrel J., Van Nueten, Luc, Drevets, Wayne C.
Publicado 2020